Pressroom

Fresh Meadows, NY, September 1, 2021–Data Conversion Laboratory (DCL), a leader in structured data and content transformations, and EVRYTHNG, a World Economic Forum Global Innovator, announce a strategic and technical partnership to provide smart labeling solutions to the pharma industry. The EVRYTHNG Product Cloud® manages digital identities for the world’s consumer products.

Information accuracy, traceability, and compliance are critical when delivering pharma information to patients. DCL and EVRYTHNG offer solutions that conform to escalating requirements for accurate digital content. Drug misinformation and counterfeit pharmaceuticals are on the rise, combined with the fact that increasing regulations make it difficult to physically fit required pharma information on the printed drug product packaging. The DCL and EVRYTHNG partnership addresses the challenge of providing consumers validated content, personalized to their specific needs.

Delivering curated content experiences offers a competitive advantage. The GS1 Digital Link allows any physical product to be enhanced with a digital profile that delivers information via a single link. Further, the information may be adapted at any time without having to renew the link. Optimizing content in a structured format such as XML, is the conduit that connects the GS1 link with the specific information.

“This collaboration provides smart contextualized labeling solutions to pharma and biotech companies,” states Mark Gross, President at DCL. “Beyond smart labeling, content structure is the building block for digital transformation in all areas of an organization. EVRYTHNG’s leadership in the GS1 Digital Link standard enables direct communication with end users in ways that were previously impossible.”

DCL converts PDF and Microsoft Word and other content into standardized XML and HTML formats, adapting to the exacting requirements of global health authorities. EVRYTHNG creates a GS1 Digital Link, which provides the gateway between the structured content and the end user communication. While delivering curated content experiences offers pharma organizations a clear competitive advantage, having continually updated information serves the important purpose of reducing adverse drug reactions, and structured content allows for accessible information for visually and cognitively impaired people.

“As we transition into our post-pandemic world, the full value chain is increasingly important,” explains Niall Murphy, Co-Founder and CEO at EVRYTHNG. “Partnering with DCL on smart labeling as well as other consumer experiences is a win-win for the company and the end user—delivering accurate, up-to-date customer information and meaningful metrics on how the user engages with content.”